Triclabendazole | Interleukin Related interleukin-related.com

Product Name :
Triclabendazole

Search keywords :
Cytosine

drugId :
null

Target Vo:
DNA (cytosine-5)-methyltransferase 1

Target Vo Short Name :
DNMT1

Moa_Name:
DNA (cytosine-5)-methyltransferase 1 inhibitors

First Approval Country :
Iran

First Approval Date Filter:
1989

Origin Company_Name :
Novartis Pharma Ag

Active Company_Name :
Novartis Pharma Ag

Active Indication_Name:
Fascioliasis

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Carbonic anhydrase 9 Antibody
Phospho-MEK1 (Thr292) Antibody
SREBP1 Antibody: SREBP1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 122 kDa, targeting to SREBP1. It can be used for WB,ELISA assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts